Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Psychosom Med. 2022 Feb-Mar;84(2):215–223. doi: 10.1097/PSY.0000000000001027

Table 1. Patient Characteristics.

Baseline demographics, smoking status, treatment, lung cancer type, and first line treatment for the 157 patients enrolled.

Level N (%) or Mean (SD)
Total Sample 157 (100)
Age in Years) 63.76 (10.74)
Sex (%) Female 68 (43.3)
Male 89 (56.7)
Race (%) White 146 (93.0)
Black or African American 11 ( 7.0)
Married/Partnered (%) No 68 (43.3)
Yes 89 (56.7)
Education (%) < High school 20 (12.7)
High school 55 (35.0)
> High school 82 (52.2)
Employed (%) No 117 (74.5)
Yes 40 (25.5)
Income (%) <=25K 33 (21.0)
>25K 109 (69.4)
Unknown 15 ( 9.6)
Smoking Status (%) Never smoker 21 (13.4)
Former smoker 110 (70.1)
Current smoker 26 (16.6)
Cancer Type (%) Adenocarcinoma 116 (73.9)
Squamous 26 (16.6)
Other 15 ( 9.6)
Treatment (%) None 10 ( 6.4)
Chemotherapy 36 (22.9)
Immunotherapy 32 (20.4)
Chemo+Immunotherapy 50 (31.8)
Targeted therapy 29 (18.5)